Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

S. Mark Blumenkranz


  • Other at Presbia Plc (LENS), 2015-08-03
  • Director at Avalanche Biotechnologies Inc. ([AAVL]), 2015-06-15
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
[AAVL] $39.97 1,900 Director 522,989 2015-06-11 Filing
[AAVL] $39.91 600 Director 524,889 2015-06-10 Filing
[AAVL] $37.35 200 Director 525,489 2015-06-09 Filing
[AAVL] $36.20 7,000 Director 525,689 2015-06-09 Filing
[AAVL] $35.52 15,300 Director 532,689 2015-06-09 Filing